Titan Biotech Ltd.
| BSE: 524717 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE150C01011 |
| BSE 00:00 | 20 Oct | 313.60 |
-8.75 (-2.71%) |
OPEN
322.00 |
HIGH
322.00 |
LOW
310.00 |
| NSE 05:30 | 01 Jan | Titan Biotech Ltd |
| OPEN | 322.00 |
| PREVIOUS CLOSE | 322.35 |
| VOLUME | 26377 |
| 52-Week high | 423.60 |
| 52-Week low | 120.05 |
| P/E | 10.66 |
| Mkt Cap.(Rs cr) | 259 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 814.75 | -1.52 | 850.00 | 452.60 | 195482.96 |
| Divi's Lab. | 5117.15 | -1.48 | 5425.00 | 3015.00 | 135834.75 |
| Dr Reddy's Labs | 4757.45 | -0.90 | 5613.65 | 4135.90 | 79163.97 |
| Cipla | 905.15 | -0.12 | 1005.00 | 706.45 | 73013.93 |
| Piramal Enterp. | 2662.55 | -3.08 | 3013.00 | 1198.90 | 63541.76 |
| Apollo Hospitals | 4144.75 | -3.65 | 5183.30 | 1987.25 | 59593.21 |
| Gland Pharma | 3539.60 | -5.27 | 4350.00 | 1701.00 | 58155.63 |
| Cadila Health. | 517.15 | -1.79 | 673.70 | 405.00 | 52940.65 |
| Torrent Pharma. | 2979.60 | -2.96 | 3248.00 | 2311.30 | 50420.79 |
| Alkem Lab | 3829.60 | -0.49 | 4067.70 | 2544.25 | 45782.87 |
| Abbott India | 20746.95 | 0.93 | 23902.30 | 13970.10 | 44087.27 |
| Lupin | 929.00 | -1.06 | 1267.50 | 856.00 | 42181.24 |
| Aurobindo Pharma | 702.00 | -1.57 | 1063.75 | 660.10 | 41130.18 |
| Biocon | 341.75 | -0.73 | 487.70 | 327.75 | 41030.50 |
| Max Healthcare | 341.40 | 1.59 | 472.60 | 102.50 | 32977.53 |
| Laurus Labs | 599.70 | -2.71 | 723.55 | 251.00 | 32179.90 |
| Dr Lal Pathlabs | 3527.10 | -4.51 | 4243.00 | 2014.00 | 29394.85 |
| Ipca Labs. | 2307.00 | -1.67 | 2767.10 | 1786.05 | 29264.30 |
| Glaxosmi. Pharma | 1469.55 | 0.30 | 1765.95 | 1379.00 | 24895.65 |
| Syngene Intl. | 606.45 | -0.67 | 699.95 | 490.35 | 24306.52 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
